» Articles » PMID: 34027712

Recommendations for Increasing Physician Provision of Pre-Exposure Prophylaxis: Implications for Medical Student Training

Abstract

There is growing evidence that pre-exposure prophylaxis (PrEP) prevents HIV acquisition. However, in the United States, approximately only 4% of people who could benefit from PrEP are currently receiving it, and it is estimated only 1 in 5 physicians has ever prescribed PrEP. We conducted a scoping review to gain an understanding of physician-identified barriers to PrEP provision. Four overarching barriers presented in the literature: Purview Paradox, Patient Financial Constraints, Risk Compensation, and Concern for ART Resistance. Considering the physician-identified barriers, we make recommendations for how physicians and students may work to increase PrEP knowledge and competence along each stage of the PrEP cascade. We recommend adopting HIV risk assessment as a standard of care, improving physician ability to identify PrEP candidates, improving physician interest and ability in encouraging PrEP uptake, and increasing utilization of continuous care management to ensure retention and adherence to PrEP.

Citing Articles

Addressing Pre-exposure Prophylaxis Awareness and Knowledge Gaps Among Lebanese Medical Professionals: A Cross-Sectional Study.

Azzi A, Chartouni C, Sakr C, Ibrahim R, Bou Chebel Z, Haddad E J Med Educ Curric Dev. 2024; 11:23821205241307735.

PMID: 39717222 PMC: 11664515. DOI: 10.1177/23821205241307735.


A Scoping Review on the Impact of COVID 19 on Vulnerable Populations: LGBTQ+ Persons, Persons Experiencing Homelessness, and Migrant Farm Workers in the US.

Alcendor D, Juarez P, Ramesh A, Brown K, Tabatabai M, Matthews-Juarez P Arch Intern Med Res. 2024; 7(3):136-145.

PMID: 39301228 PMC: 11412071. DOI: 10.26502/aimr.0172.


HIV Pre-Exposure Prophylaxis Education in Family Medicine Clerkships: A CERA Study.

Sonoda K, Everard K Fam Med. 2024; 56(5):313-316.

PMID: 38506702 PMC: 11216772. DOI: 10.22454/FamMed.2024.720928.


Differences Between General Internal Medicine and Family Medicine Physicians' Initiation of Pre-Exposure Prophylaxis.

Drallmeier T, Salas J, Keegan Garrett E, Meyr A, Tucker J, Scherrer J J Prim Care Community Health. 2023; 14:21501319231201784.

PMID: 37795848 PMC: 10557417. DOI: 10.1177/21501319231201784.


Patient perspectives on the role of nurses in HIV pre-exposure prophylaxis care (PrEP-RN).

Orser L, OByrne P, Holmes D PLoS One. 2023; 18(7):e0288283.

PMID: 37467214 PMC: 10355386. DOI: 10.1371/journal.pone.0288283.


References
1.
Spinner C, Boesecke C, Zink A, Jessen H, Stellbrink H, Rockstroh J . HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2015; 44(2):151-8. DOI: 10.1007/s15010-015-0850-2. View

2.
Bradley H, Rosenthal E, Barranco M, Udo T, Sullivan P, Rosenberg E . Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States. J Infect Dis. 2020; 222(Suppl 5):S218-S229. PMC: 8176905. DOI: 10.1093/infdis/jiaa318. View

3.
Siegler A, Mouhanna F, Mera Giler R, Weiss K, Pembleton E, Guest J . The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018; 28(12):841-849. PMC: 6286209. DOI: 10.1016/j.annepidem.2018.06.005. View

4.
Campbell J, Herbst J, Koppenhaver R, Smith D . Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV. Am J Prev Med. 2012; 44(1 Suppl 2):S63-9. DOI: 10.1016/j.amepre.2012.09.045. View

5.
Arnold E, Hazelton P, Lane T, Christopoulos K, Galindo G, Steward W . A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One. 2012; 7(7):e40603. PMC: 3394704. DOI: 10.1371/journal.pone.0040603. View